Tokyo, Japan

Ryuzi Katoh

This inventor holds 1 USPTO granted patent. Top assignees: Fujifilm Wako Pure Chemical Corporation, Nihon University. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ryuzi Katoh. Retrieved from https://idiyas.com/inventor/ryuzi-katoh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ryuzi Katoh: Innovator in Reverse Photochromic Compounds

Introduction

Ryuzi Katoh is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of photochromic compounds, particularly in medical applications. His innovative work focuses on enhancing the sensitivity of compounds to specific wavelengths of light.

Latest Patents

Ryuzi Katoh holds a patent for a reverse photochromic compound. This invention addresses the challenges faced by existing compounds in sensing light with wavelengths of 600 nm or greater. The objective of his invention is to provide a compound and polymer that exhibit high sensitivity to such light, which is crucial for various medical applications. The patent describes a compound represented by a specific general formula, detailing the various components and their functions.

Career Highlights

Throughout his career, Ryuzi Katoh has worked with prominent organizations, including Fujifilm Wako Pure Chemical Corporation and Nihon University. His experience in these institutions has contributed to his expertise in the field of chemical compounds and their applications.

Collaborations

Ryuzi Katoh has collaborated with notable colleagues, including Masami Enoki and Kazuki Nemoto. These partnerships have likely enriched his research and development efforts in the area of photochromic compounds.

Conclusion

Ryuzi Katoh's work in reverse photochromic compounds represents a significant advancement in the field, particularly for medical applications. His innovative approach and collaborations have positioned him as a key figure in this area of research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…